A novel telomerase-derived peptide GV1001-mediated inhibition of angiogenesis: Regulation of VEGF/VEGFR-2 signaling pathways

Translational Oncology(2022)

引用 4|浏览4
暂无评分
摘要
•GV1001, a human telomerase-derived peptide, inhibits endothelial cell proliferation, migration, invasion, tube formation and microvessel sprouting.•GV1001 regulates VEGF-A-stimulated signaling network components including FAK, Src, MEK, ERK and AKT pathways.•GV1001 suppresses VEGF-A-induced expression of VEGFR-2 and MMP-2.
更多
查看译文
关键词
GV1001,Telomerase-derived peptide,Angiogenesis,VEGF,Non-small cell lung cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要